Related Experiment Video
Updated: Jun 30, 2026

07:37
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
Radiological classification of optic pathway gliomas: experience of a modified functional classification system.
1Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham NG7 2UH, UK.
The British Journal of Radiology
|September 18, 2008
Summary
A modified Dodge classification (MDC) offers a more detailed anatomical assessment of childhood optic pathway gliomas (OPGs) compared to the historical Dodge classification (DC). This improved classification aids in understanding tumor characteristics and guiding clinical trials for OPGs.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Medical Imaging
Background:
- Childhood optic pathway gliomas (OPGs) are often linked to neurofibromatosis type 1 (NF1).
- The historical Dodge classification (DC) for OPGs has limitations with modern imaging techniques.
- Accurate anatomical classification is crucial for treatment and research in OPGs.
Purpose of the Study:
- To evaluate the feasibility and detail of a modified Dodge classification (MDC) for OPGs using MRI.
- To compare the MDC with the traditional DC in a cohort of pediatric OPG patients.
- To identify differences in tumor location based on NF1 status using the MDC.
Main Methods:
- A modified Dodge classification (MDC) was applied to MRI scans of 72 pediatric OPG patients.
- Patients were recruited from four centers participating in an international clinical trial.
- Tumor locations were analyzed and compared between NF1-positive and NF1-negative groups.
Main Results:
- The MDC proved feasible, applicable, and provided more detailed anatomical descriptions than the DC.
- NF1-positive OPGs more frequently involved both optic nerves and multiple locations.
- NF1-negative OPGs were more commonly found in the central chiasm and hypothalamus.
- Concordance between DC and MDC was observed in 70.8% of cases.
Conclusions:
- The modified Dodge classification (MDC) is a superior system for detailed anatomical assessment of OPGs via MRI.
- The MDC effectively differentiates tumor characteristics between NF1-positive and NF1-negative pediatric patients.
- The MDC is recommended for use in future clinical trials for OPG treatments.

